We are live on ! Find out more
MDNA

Medicenna Therapeutics Corp. Common Shares
MDNA

Delisted

MDNA was delisted on the 1st of November, 2023.

Back to rankings

28 hedge funds and large institutions have $8.11M invested in Medicenna Therapeutics Corp. Common Shares in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

50% more capital invested

Capital invested by funds: $5.41M → $8.11M (+$2.69M)

47% more funds holding

Funds holding: 19 → 28 (+9)

Holders
28
Holders Change
+9
Holders Change %
+47.37%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$1.78M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$1.13M
3
DCM
DAFNA Capital Management
California
+$745K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$734K
5
EAM
Empery Asset Management
New York
+$665K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$226K
2
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$30.5K
3
Millennium Management
Millennium Management
New York
-$4.73K
4
TRCT
Tower Research Capital (TRC)
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$3.19M +$1.78M +1,577,454 +69%
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$830K +$1.13M +1,000,000 New
WVP
3
Worth Venture Partners
New Jersey
$799K +$443K +392,312 +69%
DCM
4
DAFNA Capital Management
California
$548K +$745K +660,000 New
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$539K +$734K +650,000 New
EAM
6
Empery Asset Management
New York
$489K +$665K +589,316 New
Verition Fund Management
7
Verition Fund Management
Connecticut
$447K – – –
GPCM
8
Granite Point Capital Management
Massachusetts
$270K +$367K +325,000 New
SPC
9
Sigma Planning Corp
Michigan
$218K +$12.4K +11,000 +4%
ACM
10
ACT Capital Management
Pennsylvania
$124K – – –
MS
11
Maven Securities
Jersey
$124K +$169K +150,000 New
TAM
12
Tocqueville Asset Management
New York
$97K +$5.08K +4,500 +4%
RG
13
Rathbones Group
United Kingdom
$87K +$74.1K +65,663 +164%
LBA
14
Letko, Brosseau & Associates
Quebec, Canada
$83K – – –
MCWS
15
McKinley Carter Wealth Services
West Virginia
$66K – – –
Renaissance Technologies
16
Renaissance Technologies
New York
$38K +$15K +13,300 +41%
AC
17
Annandale Capital
Texas
$33K +$45.2K +40,000 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$28K – – –
WAM
19
Warberg Asset Management
Illinois
$24K +$33.3K +29,500 New
Osaic Holdings
20
Osaic Holdings
Arizona
$18K – – –
GVAG
21
Great Valley Advisor Group
Delaware
$16K – – –
PFGIA
22
Patriot Financial Group Insurance Agency
Massachusetts
$16K +$1.69K +1,500 +8%
Millennium Management
23
Millennium Management
New York
$10K -$4.73K -4,188 -26%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$5K +$479 +424 +8%
Toronto Dominion Bank
25
Toronto Dominion Bank
Ontario, Canada
$2K -$30.5K -27,003 -93%
1
2

MDNA Hedge Fund Activity: Q3 2022 in Review

28 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Medicenna Therapeutics Corp. Common Shares (MDNA) for Q3 2022, worth a combined $8.11M — up 50% from $5.41M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MDNA positions and 1 closed out — a net gain of 9 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was AIGH Capital Management, adding an estimated $1.78M. The largest seller was Morgan Stanley, cutting an estimated $226K.

  • 28 institutional investors held Medicenna Therapeutics Corp. Common Shares (MDNA) as of Q3 2022, up from 19 in Q2 2022.
  • Funds reported $8.11M of Medicenna Therapeutics Corp. Common Shares stock for Q3 2022, up 50% quarter-over-quarter.
  • 10 funds opened new Medicenna Therapeutics Corp. Common Shares positions in Q3 2022 and 1 closed out, a net change of +9 holders.
  • The largest Medicenna Therapeutics Corp. Common Shares buyer in Q3 2022 was AIGH Capital Management, an estimated $1.78M added.
  • The largest Medicenna Therapeutics Corp. Common Shares seller in Q3 2022 was Morgan Stanley, an estimated $226K sold.

Based on aggregated 13F filings for Q3 2022.